Patent Assignment
Reel/Frame 072278/0208
Corrective Assignment to Correct the Conveying Party Should Read Ipf Fund Ii Sca, Sicav-Fiar Previously Recorded on Reel 70839 Frame 665. Assignor(S) Hereby Confirms the Release of Security Interest.
Recorded: 2025-08-29
Pages: 5
Assignor
IPF FUND II SCA, SICAV-FIAR
Executed: 2025-04-04
Assignee
FARON PHARMACEUTICA LS LTD
JOUKAHAISEUKATU 6, TURKU, 20520, FINLAND
Covered Properties
(4)
Humanized Anti Clever-1 Antibodies and Their Use
Stable Anti-Clever-1 Antibody Formulation
Application:
18/001,689 →
Publication:
US 2023/0235046
Treatment of Cancer with Clever-1 Inhibition in Combination with Pd-1/Pd-L1 Inhibitor
Application:
17/254,795 →
Publication:
US 2021/0261657
Method of Monitoring the Efficacy of the Anti-Clever-1 Therapy in Cancer
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2020
From: HOLLMÉN, MAIJA-LEENA; VIITALA, MIRO; JALKANEN, MARKKU; MAKSIMOW, MIKAEL
To: FARON PHARMACEUTICALS OY
Reel/Frame 053796/0419 →
Assignment of Assignor's Interest
Dec 22, 2020
From: HOLLMÉN, MAIJA-LEENA; VIITALA, MIRO
To: FARON PHARMACEUTICALS OY
Reel/Frame 055871/0952 →
Assignment of Assignor's Interest
Dec 14, 2022
From: MANDELIN, JAMI; VAINIO, MARITA
To: FARON PHARMACEUTICALS OY
Reel/Frame 062090/0369 →
Security Interest
May 16, 2023
From: FARON PHARMACEUTICALS LTD
To: IPF FUND II SCA, SICAV-FIAR
Reel/Frame 063651/0807 →
Release of Security Interest
Apr 15, 2025
From: IPF FUND II SCA, SICAV-FIAR
To: FARON PHARMACEUTICALS LTD
Reel/Frame 070839/0665 →
Assignment of Assignor's Interest
Jun 4, 2025
From: MAKSIMOW, MIKAEL; JALKANEN, MARKKU; VAINIO, MARITA
To: FARON PHARMACEUTICALS OY
Reel/Frame 071318/0952 →